Conference News

DUBLIN--(BUSINESS WIRE)--Prothena partners presented clinical data updates for prasinezumab for Parkinson’s and BMS-986446 for Alzheimer’s disease at AD/PD™ 2026...

DENVER--(BUSINESS WIRE)--Cleerly, a leader in AI-based cardiovascular imaging analysis, presented findings from its multicenter INVICTUS registry at the recent European Congress of Radiology (ECR 2026) in Vienna, Austria. The presentation titled, “Artificial Intelligence-Based CCTA Quantification of Atherosclerosis Burden: Comparison With IVUS in the INVICTUS Registry” was presented by Rine Nakanishi, MD, PhD, during the Clinical Trials in Radiology: Spotlight Session on March 5, 2026. The anal...

SAN ANTONIO--(BUSINESS WIRE)--pSemi, a Murata Company, Unveils Breakthrough Power Solutions for Fast Charging Mobile Devices and Next Generation Humanoid Robotics at APEC 2026...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting...

SARASOTA, Fla.--(BUSINESS WIRE)--Helios Technologies, Inc. (NYSE: HLIO) Unveils The CORE 2030 Strategy at 2026 Investor Day and Announces 33% Increase in Quarterly Dividend...

MCLEAN, Va.--(BUSINESS WIRE)--Vellox, a new suite of products from Booz Allen (NYSE: BAH), demonstrates the power of AI-native cyber defense to combat pervasive threats....

FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that five abstracts, including one late-breaking submission, have been accepted for presentation at the 2026 Global Angioedema Leadership Conference taking place in Madrid, Spain from March 26–29, 2026. The following late-breaking abstract will be presented during the poster session on Friday, March 27 and as an oral presentation on Saturday, March 28 at 11:50 am CET: On-demand...

MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced that it will take part in a workshop and present three posters at the upcoming SIRS 2026 Annual Congress taking place March 25-29, 2026, at the exhibition and congress area Firenze Fiera in Florence, Italy. Workshop Wednesday,...

NEW DELHI--(BUSINESS WIRE)--Fortis Healthcare has been honored with six prestigious awards at the FICCI Advantage Healthcare India, International Summit on Medical Value Travel....

MUNICH--(BUSINESS WIRE)--The Future of AI Is Physical: QCraft CEO Dr. James Yu Shares His Vision at Munich's Intelligent Vehicles & Production Conference...